Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ · Healthcare
Aurinia Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Aurinia Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were 581.3M, a 54.00% increase year-over-year.
- Aurinia Pharmaceuticals Inc. shareholder equity for 2025 were 581.3M, a 54.00% increase from 2024.
- Aurinia Pharmaceuticals Inc. shareholder equity for 2024 were 377.5M, a 0.13% decrease from 2023.
- Aurinia Pharmaceuticals Inc. shareholder equity for 2023 were 378.0M, a 6.78% decrease from 2022.
- Aurinia Pharmaceuticals Inc. shareholder equity for 2022 were 405.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aurinia Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $581 |
| 2024 | $377 |
| 2023 | $378 |
| 2022 | $405 |
| 2021 | $479 |
| 2020 | $408 |
| 2019 | $299 |
| Aurinia Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $581 |
| 2024-12-31 | $377 |
| 2023-12-31 | $378 |
| 2022-12-31 | $405 |
| 2021-12-31 | $479 |
| 2020-12-31 | $408 |
| 2019-12-31 | $299 |
Aurinia Pharmaceuticals Inc. Shareholder Equity — FAQ
Aurinia Pharmaceuticals Inc. (AUPH) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AUPH's shareholder equity history?
The chart and table above show Aurinia Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.